Radiologisches Vorgehen bei der Durchführung einer SIRT

Zusammenfassung

Dieser Artikel bietet eine Übersicht über die Aufgaben des Radiologen im Rahmen der interdisziplinär durchgeführten selektiven internen Radiotherapie (SIRT). Folgende Themen werden behandelt: 1. Aufgaben der präinterventionellen Schnittbildgebung, 2. Inhalte der vorbereitenden Angiografie, 3. Ablauf der SIRT, 4. Besonderheiten radiologischer Verlaufskontrolluntersuchungen nach SIRT.

Abstract

This article focuses on the radiologist's perspective within an interdisciplinary approach when performing selective internal radiation therapy (SIRT). The following topics are addressed: 1. Goals of pre-interventional cross-sectional imaging, 2. preparing angiography, 3. SIRT procedure, 4. special features of radiological follow-up after SIRT.

Schlüsselwörter

Radioembolisation - SIRT - selektive interne Radiotherapie - Mikrosphären

Key words

radioembolization - SIRT - selective internal radiotherapy - microspheres

Literatur

• 1 Antoch G, Mueller SP, Hamami M. et al . Df Selective internal radiotherapy (SIRT) for hepatocellular carcinoma.  Rofo. 182 660-670
• 2 Atassi B, Bangash AK, Bahrani A. et al . Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.  Radiographics. 2008;  28 81-99
• 3 Bilbao JI, Garrastachu P, Herraiz MJ. et al . Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors.  Cardiovasc Intervent Radiol. 33 523-531
• 4 Carr BI. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients.  Liver Transpl. 2004;  10 S107-S110
• 5 Geschwind JF, Salem R, Carr BI. et al . Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.  Gastroenterology. 2004;  127 S194-S205
• 6 Goin JE, Salem R, Carr BI. et al . Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.  J Vasc Interv Radiol. 2005;  16 195-203
• 7 Hamami ME, Poeppel TD, Muller S P. et al . SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.  J Nucl Med. 2009;  50 688-692
• 8 Heusner TA, Hamami ME, Ertle J. et al . Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization.  Rofo. 182 603-608
• 9 Hilgard P, Hamami M, Fouly AE. et al . Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.  Hepatology. 52 1741-1749
• 10 Hilgard P, Muller S, Hamami M. et al . Selective internal radiotherapy (radioembolization) and radiation therapy for HCC – current status and perspectives.  Z Gastroenterol. 2009;  47 37-54
• 11 Ho S, Lau WY, Leung TW. et al . Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.  Eur J Nucl Med. 1996;  23 947-952
• 12 Ho S, Lau WY, Leung TW. et al . Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin.  Br J Radiol. 1997;  70 823-828
• 13 Hung JC, Redfern MG, Mahoney DW. et al . Evaluation of macroaggregated albumin particle sizes for use in pulmonary shunt patient studies.  J Am Pharm Assoc (Wash). 2000;  40 46-51
• 14 Inarrairaegui M, Thurston KG, Bilbao JI. et al . Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.  J Vasc Interv Radiol. 21 1205-1212
• 15 Kao YH, Tan AE, Khoo LS. et al . Hepatic falciform ligament Tc-99m-macroaggregated albumin activity on SPECT/CT prior to Yttrium-90 microsphere radioembolization: prophylactic measures to prevent non-target microsphere localization via patent hepatic falciform arteries.  Ann Nucl Med,. Jan14 (Epub ahead of print)
• 16 Kennedy AS, McNeillie P, Dezarn WA. et al . Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.  Int J Radiat Oncol Biol Phys. 2009;  74 1494-1500
• 17 Leung TW, Lau WY, Ho SK. et al . Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma.  Cancer Chemother Pharmacol. 1994;  33 (Suppl:) S33-S36
• 18 Lewandowski RJ, Sato KT, Atassi B. et al . Radioembolization with 90Y microspheres: angiographic and technical considerations.  Cardiovasc Intervent Radiol. 2007;  30 571-592
• 19 Liu DM, Salem R, Bui JT. et al . Angiographic considerations in patients undergoing liver-directed therapy.  J Vasc Interv Radiol. 2005;  16 911-935
• 20 McWilliams JP, Kee ST, Loh CT. et al . Prophylactic Embolization of the Cystic Artery Before Radioembolization: Feasibility, Safety, and Outcomes.  Cardiovasc Intervent Radiol. 2010, Nov 18 (Epub ahead of print)
• 21 Michels NA. Newer anatomy of the liver and its variant blood supply and collateral circulation.  Am J Surg. 1966;  112 337-347
• 22 Murthy R, Brown DB, Salem R. et al . Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.  J Vasc Interv Radiol. 2007;  18 553-561 ; quiz 562
• 23 Riaz A, Kulik L, Lewandowski RJ. et al . Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres.  Hepatology. 2009;  49 1185-1193
• 24 Riaz A, Lewandowski RJ, Kulik LM. et al . Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review.  J Vasc Interv Radio. 2009;  20 1121-1130 ; quiz 113.
• 25 Riaz A, Miller FH, Kulik LM. et al . Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.  Jama. 303 1062-1069
• 26 Salem R, Lewandowski RJ, Gates VL. et al . Research reporting standards for radioembolization of hepatic malignancies.  J Vasc Interv Radiol. 22 265-278
• 27 Salem R, Lewandowski RJ, Mulcahy MF. et al . Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.  Gastroenterology. 138 52-64
• 28 Salem R, Lewandowski RJ, Sato KT. et al . Technical aspects of radioembolization with 90Y microspheres.  Tech Vasc Interv Radiol. 2007;  10 12-29
• 29 Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.  J Vasc Interv Radiol. 2006;  17 1251-1278
• 30 Salem R, Thurston KG. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.  J Vasc Interv Radiol. 2006;  17 1425-1439

Korrespondenzadresse